Close
CDMO Safety Testing 2026
Novotech

Ashfield Engage acquires smart data organization PROPENSITY4

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.
- Advertisement -

Ashfield Engage, part of UDG Healthcare has acquired PROPENSITY4 – a ‘smart data’ organization and leader in the healthcare insights and analytics arena.

PROPENSITY4 integrates internal and external data assets and applies the right methodologies to derive detailed insight using proprietary analytical platforms that enables data-performance driven strategy. The acquisition follows multiple years of partnership, and an investment into PROPENSITY4 by Ashfield Engage in 2021.

Ashfield made the decision to acquire the business following the success of multiple projects which have integrated the companies’ offering to provide clients with better approaches to omnichannel outreach and customer engagement on a global level.

The acquisition will further Ashfield’s capability to apply analytical expertise to existing data to redesign programs which increase return on investment across commercial, patient engagement and medical affairs services, and improve patient outcomes.

Christopher Savage, Global Head of Strategy at Ashfield Engage, said: “Ashfield Engage works across the pharmaceutical industry, including top 20 pharma and emerging biotech, to establish and maintain exceptional relationships with the various healthcare stakeholders throughout the commercialisation journey.”

“Our customer engagement expertise, combined with the unparalleled data analytics we have gained through the acquisition of PROPENSITY4, will allow us to supersize our offering, ensuring we’re delivering the right message to the right customer at the right time in the right channel to maximize impact.”

“We have already seen exceptional outcomes as a result of our collaborations. This shows that by applying analytical expertise to existing data, we can redesign engagement models which provide excellent results.”

PROPENSITY4 uses proprietary analytical platforms alongside detailed market insight to inform engagement pathways with HCPs, which ultimately benefits patients.

Sese Abhulimen, Managing Director at PROPENSITY4, said: “We’re excited to be joining an organization we already have a strong partnership with. PROPENSITY4 was created to move away from project-specific analytics to a big-picture approach, ensuring that data, analytics and insights are tied together to drive strategy across payers, patients and healthcare professionals.

“We have always strived to be held accountable to the range of analytic outcomes we generate for our clients, and our partnership with Ashfield Engage has seen us not only further deliver on this goal but also provide exceptional ROI for our valued clients.”

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Novartis Expands Radioligand Therapy Manufacturing in US

Swiss pharmaceutical company Novartis has started construction of a...

AI-Driven Cold Chains Transforming Pharma Supply Systems

The integration of artificial intelligence into cold chain management is reshaping the pharmaceutical supply landscape. AI-driven cold chains utilize predictive visibility and intelligent thermal control to optimize logistics operations across global networks. By anticipating risks and automating complex decisions, these systems ensure the integrity of temperature-sensitive medications, significantly enhancing the reliability and efficiency of pharmaceutical distribution on a global scale.

Cold Chain Intelligence Enhancing Pharma Logistics Safety

Global pharmaceutical logistics faces unprecedented challenges in maintaining product integrity during transit. Cold chain intelligence offers a sophisticated solution by integrating predictive monitoring and thermal assurance into a connected supply chain. This approach ensures that life-saving medications and vaccines reach their destination without compromising safety or efficacy, marking a significant evolution in healthcare distribution.

Digital Supply Networks Strengthening Pharma Delivery

The transition from traditional linear supply chains to integrated digital supply networks is revolutionizing how pharmaceutical products are delivered. By leveraging connected visibility and real-time analytics, these networks enhance the resilience of cold chain operations. This technological evolution ensures that healthcare systems can respond dynamically to shifts in demand while maintaining the highest standards of safety and efficiency for patient care.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »